Low-dose alemtuzumab in refractory/relapsed chronic lymphocytic leukemia: Genetic profile and long-term outcome from a single center experience-Reference-Cited by-同舟云学术

Low-dose alemtuzumab in refractory/relapsed chronic lymphocytic leukemia: Genetic profile and long-term outcome from a single center experience

Published:2015-08-14 Issue:11 Volume:90 Page:970-974
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Sciumè Mariarita¹,Vincenti Daniele¹,Reda Gianluigi¹,Orofino Nicola¹,Cassin Ramona¹,Giannarelli Diana²,Gaidano Gianluca³,Rossi Davide³,Cortelezzi Agostino¹

Affiliation:

1. Hematology Unit, IRCCS Ca'granda Ospedale Maggiore Policlinico and University of Milan; via Francesco Sforza, 35 Milan Italy

2. Biostatistics Unit, Regina Elena Institute for Cancer Research and Treatment; via Elio Chianesi, 53 Rome Italy

3. Division of Hematology; Dept. Of Translational Medicine; A. Avogadro University of Eastern Piedmont; Corso, Mazzini, 18 Novara Italy

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.24127/fullpdf

Reference37 articles.

1. Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment;Hallek;Am J Hematol,2015

2. Genomic aberrations and survival in chronic lymphocytic leukemia;Döhner;N Engl J Med,2000

3. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: A report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines;Hallek;Blood,2008

4. Non-Hodgkin lymphoma subtype distribution, geo-demographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998-2011;Al-Hamadani;Am J Hematol

5. Salvage outcomes in patients with first relapse after fludarabine, cyclophosphamide, and rituximab for chronic lymphocytic leukemia: The French intergroup experience;Fornecker;Am J Hematol,2015

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dendrimer-based nanoparticles for potential personalized therapy in chronic lymphocytic leukemia: Targeting the BCR-signaling pathway;International Journal of Biological Macromolecules;2016-07

2. Therapeutic Use of Biologic Agents in Systemic Vasculitides;Systemic Vasculitides: Current Status and Perspectives;2016